TY - JOUR
T1 - Defining ‘T cell exhaustion’
AU - Blank, Christian U.
AU - Haining, W. Nicholas
AU - Held, Werner
AU - Hogan, Patrick G.
AU - Kallies, Axel
AU - Lugli, Enrico
AU - Lynn, Rachel C.
AU - Philip, Mary
AU - Rao, Anjana
AU - Restifo, Nicholas P.
AU - Schietinger, Andrea
AU - Schumacher, Ton N.
AU - Schwartzberg, Pamela L.
AU - Sharpe, Arlene H.
AU - Speiser, Daniel E.
AU - Wherry, E. John
AU - Youngblood, Benjamin A.
AU - Zehn, Dietmar
N1 - Publisher Copyright:
© 2019, This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - ‘T cell exhaustion’ is a broad term that has been used to describe the response of T cells to chronic antigen stimulation, first in the setting of chronic viral infection but more recently in response to tumours. Understanding the features of and pathways to exhaustion has crucial implications for the success of checkpoint blockade and adoptive T cell transfer therapies. In this Viewpoint article, 18 experts in the field tell us what exhaustion means to them, ranging from complete lack of effector function to altered functionality to prevent immunopathology, with potential differences between cancer and chronic infection. Their responses highlight the dichotomy between terminally differentiated exhausted T cells that are TCF1– and the self-renewing TCF1+ population from which they derive. These TCF1+ cells are considered by some to have stem cell-like properties akin to memory T cell populations, but the developmental relationships are unclear at present. Recent studies have also highlighted an important role for the transcriptional regulator TOX in driving the epigenetic enforcement of exhaustion, but key questions remain about the potential to reverse the epigenetic programme of exhaustion and how this might affect the persistence of T cell populations.
AB - ‘T cell exhaustion’ is a broad term that has been used to describe the response of T cells to chronic antigen stimulation, first in the setting of chronic viral infection but more recently in response to tumours. Understanding the features of and pathways to exhaustion has crucial implications for the success of checkpoint blockade and adoptive T cell transfer therapies. In this Viewpoint article, 18 experts in the field tell us what exhaustion means to them, ranging from complete lack of effector function to altered functionality to prevent immunopathology, with potential differences between cancer and chronic infection. Their responses highlight the dichotomy between terminally differentiated exhausted T cells that are TCF1– and the self-renewing TCF1+ population from which they derive. These TCF1+ cells are considered by some to have stem cell-like properties akin to memory T cell populations, but the developmental relationships are unclear at present. Recent studies have also highlighted an important role for the transcriptional regulator TOX in driving the epigenetic enforcement of exhaustion, but key questions remain about the potential to reverse the epigenetic programme of exhaustion and how this might affect the persistence of T cell populations.
UR - http://www.scopus.com/inward/record.url?scp=85074300816&partnerID=8YFLogxK
U2 - 10.1038/s41577-019-0221-9
DO - 10.1038/s41577-019-0221-9
M3 - Article
C2 - 31570879
AN - SCOPUS:85074300816
SN - 1474-1733
VL - 19
SP - 665
EP - 674
JO - Nature Reviews Immunology
JF - Nature Reviews Immunology
IS - 11
ER -